Cellyan Biotechnology Co. Class AHKPD
13F holders, Q1 2025 (March 31)4holders
$1.08avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Cellyan Biotechnology Co. Class A (HKPD) in their 13F filings. The largest holders were Jane Street Group, LLC ($22K), Clear Street LLC ($17K) and Warberg Asset Management LLC ($16K).
- Company
- Cellyan Biotechnology Co. Class A
- Filed as
- HONG KONG PHARMA DIGITAL TEC (Q1 2025)
- CUSIP
- G6365B104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $56K |
| Exits | 0 | $0 |
Ownership 4 holders
| Jane Street Group, LLC | 0.00% | New | 20,690 | $22K |
| Clear Street LLC | 0.00% | New | 15,719 | $17K |
| Warberg Asset Management LLC | 0.07% | New | 15,000 | $16K |
| UBS Group AG | 0.00% | New | 272 | $294 |
"% of holder's portfolio" is HKPD's weight in each manager's 13F, not the share of Cellyan Biotechnology Co. Class A the manager owns.